UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 15 19, 2016

Foundation Healthcare, Inc.

(Exact name of registrant as specified in charter)

Oklahoma

001-34171

20-0180812

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

13900 N. Portland Avenue, Suite 200

Oklahoma City, Oklahoma 73134

(Address of Principal Executive Offices) (Zip Code)

(405) 608-1700

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 21.~~02.~~01 ~~Results~~Entry ofinto ~~Operations~~a ~~and~~Material ~~Financial~~Definitive ~~Condition~~Agreement.

OnItem ~~August 15, 2016, Foundation Healthcare, Inc~~2.03 ~~announced~~Creation ~~its financial results for the quarter ended June 30, 2016. A copy~~ of ~~the~~a ~~earnings~~Direct ~~press~~Financial ~~release~~Obligation ~~is attached~~or asan ~~Exhibit~~Obligation ~~99.1~~under toan ~~this Current Report on Form 8~~Off-K.Balance ASheet ~~transcript~~Arrangement of ~~the earnings conference call is attached as Exhibit 99~~Registrant.~~2 to this Current Report on Form 8-K.~~

~~The~~On ~~information~~August 19, in2016, ~~this~~we ~~Current~~entered ~~Report~~into ona ~~Form~~Loan ~~8-K~~Modification Agreement and Waiver (the ~~exhibit~~“Senior ~~attached~~Credit ~~hereto~~Modification”) ~~shall~~with ~~not~~Texas Capital beBank, ~~deemed~~National ~~“filed”~~Association ~~for~~serving ~~purposes~~as ofthe ~~Section 18~~lead ~~of the~~bank ~~Securities~~along ~~Exchange~~with ~~Act~~two ofother ~~1934~~commercial banks (~~the~~collectively “~~Exchange~~Senior ~~Act~~Lenders”). Under orthe ~~otherwise~~Senior ~~subject~~Credit toModification, the ~~liabilities~~Senior ofLenders ~~that~~waived ~~section,~~our ~~nor~~financial ~~shall~~covenant itviolations befor the ~~deemed~~fiscal ~~incorporated~~quarter byended ~~reference~~June 30, in2016 ~~any~~and ~~filing~~modified ~~under~~the financial covenants for the ~~Securities~~fiscal ~~Act~~quarters ofending ~~1933~~September 30, or2016 and December 31, 2016 by replacing the ~~Exchange~~Debt ~~Act~~to EBITDA Ratio, ~~except~~Senior Debt to EBITDA Ratio, and Pre and Post asDistribution ~~expressly~~Fixed ~~set~~Charge ~~forth~~Coverage byRatios ~~specific~~with ~~reference~~the inan ~~such~~EBITDA acovenant ~~filing.~~as follows:

EBITDA. We must have EBITDA of at least $1,750,000 for the fiscal quarter ending September 30, 2016 and $4,250,000 for the fiscal quarter ending December 31, 2016.

In addition, the Senior Lenders extended the due date for the repayment of a $3 million advance on our Revolving Loan from July 31, 2016 to January 15, 2017. During the period from August 19, 2016 to June 30, 2017, the Senior Credit Modification prohibits us from making any interest or redemption payments to our preferred noncontrolling interest holders and prohibits us from making any payments on our $7.9 million subordinated note payable. Under the Senior Credit Modification, we must also maintain total cash balances in excess of $2 million and we must maintain total accounts payable past due by 91 days or more must be less than $6.3 million. We incurred a fee of $0.2 million with our Senior Lenders for executing the Senior Credit Modification.

Item 9.01. Financial Statements and Exhibits.

~~(d)~~a. Exhibits.

ExhibitNo.		Description
Exhibit No.		Description
99.1		Earnings Press Release Issued on August 15, 2016
10.1		Loan Modification Agreement and Waiver, dated August 19, 2016, by and between Foundation Healthcare, Inc. and Texas Capital Bank, National Association.
99.2		Transcript of August 15, 2016 Earnings Conference Call

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

EXHIBIT INDEX

ExhibitNo.		Exhibit
Exhibit No.		Exhibit
99.1		Earnings Press Release Issued on August 15, 2016
10.1		Loan Modification Agreement and Waiver, dated August 19, 2016, by and between Foundation Healthcare, Inc. and Texas Capital Bank, National Association.
99.2		Transcript of August 15, 2016 Earnings Conference Call

FOUNDATION HEALTHCARE, INC.

FOUNDATION HEALTHCARE, INC.

Date: August 19, 2016

/s/ STANTON NELSON

Date: August 25, 2016

/s/ STANTON NELSON

Stanton Nelson

Chief Executive Officer

Filing Compare · Foundation Healthcare, Inc.